We are live on ! Find out more
PRHC

P.R. Herzig & Co Portfolio holdings

AUM $45.9M
1-Year Est. Return 15.88%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+15.88%
3 Year Est. Return
+49.95%
5 Year Est. Return
+89.91%
10 Year Est. Return
AUM
$51.6M
AUM Growth
+$108K
Cap. Flow
-$642K
Cap. Flow %
-1.24%
Top 10 Hldgs %
42.05%
Holding
54
New
6
Increased
7
Reduced
14
Closed
4

Top Buys

Rank Stock Value
1
HBI
Hanesbrands
HBI
+$1.13M
2
HXL icon
Hexcel
HXL
+$983K
3
SEP
Spectra Engy Parters Lp
SEP
+$396K
4
X
US Steel
X
+$313K
5
PYPL icon
PayPal
PYPL
+$236K

Top Sells

Rank Stock Value
1
PTC icon
PTC
PTC
+$1.37M
2
MHK icon
Mohawk Industries
MHK
+$574K
3
SLB icon
SLB Ltd
SLB
+$363K
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$298K
5
GE icon
GE Aerospace
GE
+$249K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.88%
2 Healthcare 16.9%
3 Technology 15.25%
4 Industrials 8.66%
5 Materials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MD icon
51
Pediatrix Medical
MD
$2.18B
-3,310
Closed -$230K
MHK icon
52
Mohawk Industries
MHK
$8.79B
-2,500
Closed -$574K
PTC icon
53
PTC
PTC
$17.2B
-26,100
Closed -$1.37M
SLB icon
54
SLB Ltd
SLB
$81.6B
-4,650
Closed -$363K

Similar funds

P.R. Herzig & Co's Q2 2017 Portfolio in Review

As of Q2 2017, P.R. Herzig & Co held 54 positions worth $51.6M, up 0.21% from $51.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

P.R. Herzig & Co's Q2 2017 filing shows 6 new, 7 increased, 14 reduced and 4 closed positions. Its largest new stake was Hanesbrands: 52,600 shares worth $1.22M. The largest sale was PTC, an estimated $1.37M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.

  • P.R. Herzig & Co's largest Q2 2017 buy was Hanesbrands: 52,600 shares worth $1.22M.
  • P.R. Herzig & Co added most to PayPal in Q2 2017, an estimated $236K increase.
  • P.R. Herzig & Co's biggest Q2 2017 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $298K.
  • P.R. Herzig & Co fully exited PTC in Q2 2017, selling an estimated $1.37M.
  • P.R. Herzig & Co's ten largest holdings make up 42% of its $51.6M portfolio in Q2 2017.
  • P.R. Herzig & Co opened 6 new positions and closed 4 in Q2 2017.
  • P.R. Herzig & Co's portfolio value rose 0.21% quarter-over-quarter to $51.6M.

Based on P.R. Herzig & Co's 13F filing for Q2 2017, filed 18 Jul 2017.